RU58841
| 製品名 | RU58841 |
|---|---|
| CAS番号 | 154992-24-2 |
| 別名 | PSK-3841; RU 58841; 4-(4,4-Dimethyl-2,5-dioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile |
| 分子式 | C13H10F3N3O2 |
| 分子量 | 297.23 g/mol |
| 外観 | 白色からオフホワイトの結晶性粉末 |
| 分析(HPLC) | ≥98.0% |
| 乾燥減量 | ≤0.5% |
| 重金属 | 10 ppm以下 |
| 溶解度 | Soluble in DMSO, ethanol; slightly soluble in water |
| パッケージ | 1 kg, 5 kg, 25 kg drums |
お困りですか? 弊社チームまでお問い合わせください

同義語: PSK-3841, RU 58841, 4-(4,4-Dimethyl-2,5-dioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile, RU-58841, 154992-24-2
RU58841 is a non-steroidal anti-androgen that has carved a niche in the research community for its topical activity against androgenetic alopecia and androgen-related skin conditions. Developed initially by Roussel Uclaf, this compound is a derivative of the topical anti-androgen flutamide, engineered to exert local effects without significant systemic absorption. It is available as a high-purity powder, typically ≥98% by HPLC, making it suitable for formulation and preclinical studies.
In the B2B arena, RU58841 is sought after by pharmaceutical and cosmetic ingredient buyers for its potential in hair care and dermatological products. Its mechanism involves competitive binding to the androgen receptor, thereby blocking dihydrotestosterone (DHT) from triggering follicle miniaturization. While not yet approved for clinical use, its profile continues to attract interest in the development of next-generation anti-hair loss solutions.
| パラメータ | 仕様 |
|---|---|
| 外観 | 白色からオフホワイトの結晶性粉末 |
| 分析(HPLC) | ≥98.0% |
| 乾燥減量 | ≤0.5% |
| 重金属 | 10 ppm以下 |
| 溶解度 | Soluble in DMSO, ethanol; slightly soluble in water |
| 粒子径 | NLT 98% through 80 mesh |